ARCADIA BIOSCIENCES INC (RKDA)
US0390143032 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.52M | 20.64M | 28.69M | 14.04M | 8.42M | |||
| Marketable Securities | 5.12M | N/A | 0.00 | 11.63M | 16.92M | |||
| Receivables | 514.00K | 1.29M | 1.37M | 1.41M | 600.00K | |||
| Inventories | 1.96M | 2.57M | 4.43M | 3.81M | 1.79M | |||
| Other Current Assets | 858.00K | 900.00K | 900.00K | 810.00K | 710.00K | |||
| Total Current Assets | 14.97M | 25.40M | 35.39M | 31.70M | 28.44M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.18M | 2.55M | 5.37M | 9.37M | 3.76M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | 0.00 | 410.00K | N/A | |||
| Intangibles | 39.00K | 40.00K | 480.00K | 370.00K | N/A | |||
| Other Non-Current Assets | 3.52M | 930.00K | 2.67M | 5.51M | 370.00K | |||
| Total Non-Current Assets | 4.73M | 3.52M | 8.53M | 15.65M | 4.13M | |||
| TOTAL ASSETS | 19.70M | 28.92M | 43.92M | 47.35M | 32.57M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 0.00 | 1.14M | 20.00K | |||
| Accrued Expenses | 2.46M | 2.96M | 3.30M | 4.10M | 4.80M | |||
| Accounts Payable | 859.00K | 980.00K | 1.48M | 810.00K | 530.00K | |||
| Other Current Liabilities | 270.00K | 270.00K | 260.00K | 270.00K | 350.00K | |||
| Total Current Liabilities | 3.59M | 4.21M | 5.04M | 6.31M | 5.71M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 2.11M | 110.00K | |||
| Other Non-Current Liabilities | 3.41M | 3.81M | 7.68M | 10.38M | 18.43M | |||
| Total Non-Current Liabilities | 3.27M | 3.68M | 7.79M | 13.31M | 19.16M | |||
| TOTAL LIABILITIES | 6.86M | 7.89M | 12.83M | 19.62M | 24.87M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -271.84M | -257.86M | -226.49M | -211.83M | -207.17M | |||
| Additional Paid In Capital | 284.51M | 278.83M | 257.52M | 239.50M | 214.83M | |||
| Minority Interest | -133.00K | 110.00K | 1.57M | 2.20M | 690.00K | |||
| Common Shares | 65.00K | 70.00K | 60.00K | 50.00K | 50.00K | |||
| Other Shareholders' Equity | 101.00K | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 1.29M | 620.00K | 550.00K | 340.00K | 220.00K | |||
| Tangible Book Value per Share | 9.96 | 33.85 | 55.65 | 79.26 | 35.05 | |||
| Total Shareholders' Equity | 12.84M | 21.03M | 31.09M | 27.73M | 7.71M | |||
| TOTAL LIABILITIES AND EQUITY | 19.70M | 28.92M | 43.92M | 47.35M | 32.57M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.08 | 0.01 | |||
| Current Ratio | 4.17 | 6.03 | 7.02 | 5.02 | 4.98 | |||
| Return On Assets (ROA) | -70.95% | -53.18% | -33.38% | -9.84% | -88.46% | |||
| Return On Equity (ROE) | -108.88% | -73.13% | -47.15% | -16.80% | -373.67% | |||
All data in USD